Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
1.390
-0.200 (-12.58%)
Apr 1, 2025, 4:00 PM EDT - Market closed
Zentalis Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Cash & Equivalents | 33.9 | 28.04 | 43.07 | 59.71 | 54.95 | Upgrade
|
| Short-Term Investments | 337.18 | 454.88 | 394.3 | 280.17 | 283.55 | Upgrade
|
| Cash & Short-Term Investments | 371.08 | 482.92 | 437.37 | 339.89 | 338.51 | Upgrade
|
| Cash Growth | -23.16% | 10.41% | 28.68% | 0.41% | 403.38% | Upgrade
|
| Accounts Receivable | 5 | - | - | - | - | Upgrade
|
| Other Receivables | - | - | - | - | 0.42 | Upgrade
|
| Receivables | 5 | - | - | - | 0.42 | Upgrade
|
| Prepaid Expenses | 9.98 | 13.8 | 14.56 | 10.64 | 6.18 | Upgrade
|
| Restricted Cash | - | - | - | 0.24 | - | Upgrade
|
| Total Current Assets | 386.07 | 496.72 | 451.93 | 350.77 | 345.1 | Upgrade
|
| Property, Plant & Equipment | 37.23 | 41.74 | 50.08 | 52.84 | 3.62 | Upgrade
|
| Long-Term Investments | - | - | 21.21 | 37.5 | - | Upgrade
|
| Goodwill | - | 3.74 | 3.74 | 3.74 | 3.74 | Upgrade
|
| Other Intangible Assets | - | - | - | - | 8.8 | Upgrade
|
| Other Long-Term Assets | 7.04 | 9.5 | 12.35 | 9.67 | 4.3 | Upgrade
|
| Total Assets | 430.34 | 551.69 | 539.31 | 454.51 | 365.56 | Upgrade
|
| Accounts Payable | 7.44 | 14.93 | 11.25 | 11.59 | 8.66 | Upgrade
|
| Accrued Expenses | 42.22 | 51.54 | 42.85 | 29.93 | 18.63 | Upgrade
|
| Current Portion of Leases | 3.07 | 2.62 | 2.16 | 1.45 | 0.9 | Upgrade
|
| Current Income Taxes Payable | - | 0.28 | 0.38 | 0.97 | 0.41 | Upgrade
|
| Total Current Liabilities | 52.73 | 69.37 | 56.65 | 43.94 | 28.6 | Upgrade
|
| Long-Term Leases | 39.58 | 43.15 | 45.17 | 44.46 | 1.1 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | 0.85 | 1.62 | 2.48 | Upgrade
|
| Other Long-Term Liabilities | 0.85 | 1.78 | 2.62 | - | - | Upgrade
|
| Total Liabilities | 93.15 | 114.3 | 105.29 | 90.03 | 32.18 | Upgrade
|
| Common Stock | 0.07 | 0.07 | 0.06 | 0.05 | 0.04 | Upgrade
|
| Additional Paid-In Capital | 1,391 | 1,324 | 1,031 | 723.59 | 509.34 | Upgrade
|
| Retained Earnings | -1,054 | -888.56 | -596.37 | -359.56 | -200.83 | Upgrade
|
| Comprehensive Income & Other | 0.56 | 2.19 | -1.35 | -0.13 | 0.04 | Upgrade
|
| Total Common Equity | 337.19 | 437.28 | 433.8 | 363.95 | 308.58 | Upgrade
|
| Minority Interest | - | 0.11 | 0.22 | 0.53 | 24.8 | Upgrade
|
| Shareholders' Equity | 337.19 | 437.39 | 434.02 | 364.48 | 333.38 | Upgrade
|
| Total Liabilities & Equity | 430.34 | 551.69 | 539.31 | 454.51 | 365.56 | Upgrade
|
| Total Debt | 42.65 | 45.77 | 47.33 | 45.91 | 2 | Upgrade
|
| Net Cash (Debt) | 328.44 | 437.15 | 390.04 | 293.98 | 336.51 | Upgrade
|
| Net Cash Growth | -24.87% | 12.08% | 32.68% | -12.64% | 406.29% | Upgrade
|
| Net Cash Per Share | 4.62 | 6.68 | 7.38 | 6.89 | 11.97 | Upgrade
|
| Filing Date Shares Outstanding | 71.81 | 70.96 | 59.42 | 45.56 | 41.04 | Upgrade
|
| Total Common Shares Outstanding | 71.28 | 70.77 | 59.28 | 45.49 | 41.04 | Upgrade
|
| Working Capital | 333.34 | 427.35 | 395.29 | 306.83 | 316.5 | Upgrade
|
| Book Value Per Share | 4.73 | 6.18 | 7.32 | 8.00 | 7.52 | Upgrade
|
| Tangible Book Value | 337.19 | 433.55 | 430.07 | 360.22 | 296.05 | Upgrade
|
| Tangible Book Value Per Share | 4.73 | 6.13 | 7.25 | 7.92 | 7.21 | Upgrade
|
| Machinery | 4.81 | 4.56 | 4.84 | 4.39 | 0.95 | Upgrade
|
| Construction In Progress | - | 0.17 | 0.04 | 0.03 | 0.35 | Upgrade
|
| Leasehold Improvements | 4.17 | 4.24 | 4.89 | 4.52 | 0.05 | Upgrade
|
Updated Mar 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.